Loading...
XIDX
PRDA
Market cap142mUSD
May 14, Last price  
2,530.00IDR
1D
-1.57%
1Q
-3.09%
Jan 2017
-56.72%
IPO
-61.38%
Name

Prodia Widyahusada Tbk PT

Chart & Performance

D1W1MN
XIDX:PRDA chart
P/E
8.78
P/S
1.05
EPS
288.21
Div Yield, %
6.61%
Shrs. gr., 5y
—
Rev. gr., 5y
5.24%
Revenues
2.25t
+1.34%
997,986,700,0791,101,043,712,6121,197,727,222,0121,358,664,085,9761,466,017,000,0001,599,757,000,0001,744,271,000,0001,873,375,000,0002,652,257,000,0002,181,642,000,0002,222,466,000,0002,252,194,000,000
Net income
270.20b
+3.97%
61,590,631,71358,560,231,45559,024,994,42288,134,987,526150,797,000,000175,450,000,000210,261,000,000268,747,000,000623,230,000,000371,647,000,000259,874,000,000270,197,000,000
CFO
0k
-100.00%
82,664,729,507105,658,756,890155,608,151,085119,253,694,64093,470,000,000239,829,000,000341,825,000,000434,631,000,000777,266,000,000496,733,000,000411,285,000,0000
Dividend
Apr 29, 2024165.9673 IDR/sh

Profile

PT Prodia Widyahusada Tbk provides private clinical laboratory services. The company offers laboratory, panel test, and other diagnostics support services. As of December 31, 2021, it operated 259 outlets comprising 10 Prodia Health Care and specialty clinic outlets, 142 clinical lab and medical labs, 98 point of care outlets, and 9 hospital collaboration labs in 34 provinces throughout Indonesia. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Prodia Widyahusada Tbk is a subsidiary of PT Prodia Utama.
URL
http://www.prodia.co.id/
IPO date
Dec 07, 2016
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,252,194,000
1.34%
2,222,466,000
1.87%
2,181,642,000
-17.74%
Cost of revenue
1,348,659,000
1,921,826,000
1,173,772,000
Unusual Expense (Income)
NOPBT
903,535,000
300,640,000
1,007,870,000
NOPBT Margin
40.12%
13.53%
46.20%
Operating Taxes
72,946,000
79,578,000
98,721,000
Tax Rate
8.07%
26.47%
9.80%
NOPAT
830,589,000
221,062,000
909,149,000
Net income
270,197,000
3.97%
259,874,000
-30.08%
371,647,000
-40.37%
Dividends
(155,594,000)
(222,988,000)
(372,974,000)
Dividend yield
6.15%
4.40%
7.08%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
16,172,000
12,929,000
14,192,000
Long-term debt
39,154,000
46,153,000
44,516,000
Deferred revenue
Other long-term liabilities
90,565,000
93,984,000
110,871,000
Net debt
(744,074,000)
(1,082,472,000)
(1,339,646,000)
Cash flow
Cash from operating activities
411,285,000
496,733,000
CAPEX
(136,704,000)
(131,546,000)
(235,297,000)
Cash from investing activities
(299,780,000)
(244,270,000)
65,388,000
Cash from financing activities
(278,025,000)
(322,458,000)
(434,586,000)
FCF
739,858,000
66,586,000
835,489,000
Balance
Cash
766,238,000
992,813,000
1,298,354,000
Long term investments
33,162,000
148,741,000
100,000,000
Excess cash
686,790,300
1,030,430,700
1,289,271,900
Stockholders' equity
1,326,540,000
1,207,463,000
1,157,998,000
Invested Capital
1,918,799,700
1,455,524,300
1,239,316,000
ROIC
49.23%
16.41%
72.27%
ROCE
34.68%
12.09%
42.04%
EV
Common stock shares outstanding
937,500
937,500
941,185
Price
2,700.00
-50.00%
5,400.00
-3.57%
5,600.00
-39.13%
Market cap
2,531,250,000
-50.00%
5,062,500,000
-3.95%
5,270,636,000
-39.42%
EV
1,789,451,000
3,982,457,000
3,933,969,000
EBITDA
903,535,000
476,193,000
1,132,956,000
EV/EBITDA
1.98
8.36
3.47
Interest
2,446,000
12,718,000
2,740,000
Interest/NOPBT
0.27%
4.23%
0.27%